Cargando…

Cannabinoids and PPAR Ligands: The Future in Treatment of Polycystic Ovary Syndrome Women with Obesity and Reduced Fertility

Cannabinoids (CBs) are used to treat chronic pain, chemotherapy-induced nausea and vomiting, and multiple sclerosis spasticity. Recently, the medicinal use of CBs has attracted increasing interest as a new therapeutic in many diseases. Data indicate a correlation between CBs and PPARs via diverse me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Przybycień, Piotr, Gąsior-Perczak, Danuta, Placha, Wojciech
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406585/ https://www.ncbi.nlm.nih.gov/pubmed/36010645 http://dx.doi.org/10.3390/cells11162569

Ejemplares similares

Impact of Central Obesity on Women with Polycystic Ovary Syndrome Undergoing In Vitro Fertilization
por: Li, Yu, et al.
Publicado: (2018)

Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
por: Froment, Pascal, et al.
Publicado: (2006)

Insulin resistance and fertility in polycystic ovary syndrome.
por: Fica, S, et al.
Publicado: (2008)

Effect of hyperlipidemia on the outcome of in vitro fertilization in non-obese patients with polycystic ovary syndrome
por: Yang, Fang, et al.
Publicado: (2023)

Fertility Treatment Options for Women With Polycystic Ovary Syndrome
por: Sawant, Shital, et al.
Publicado: (2019)

Polycystic Ovary Syndrome: Past, Present and Future
por: Meczekalski, Blazej
Publicado: (2023)

Phenotype and Metabolic Disorders in Polycystic Ovary Syndrome
por: Głuszak, Olgierd, et al.
Publicado: (2012)

Why are women with polycystic ovary syndrome obese?
por: Barber, T M
Publicado: (2022)

Characteristics and outcomes of in vitro fertilization in different phenotypes of polycystic ovary syndrome
por: Selçuk, Selçuk, et al.
Publicado: (2016)

The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-γ
por: Unluturk, Ugur, et al.
Publicado: (2007)

Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
por: Moran, Carlos, et al.
Publicado: (2012)

Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
por: Kahal, Hassan, et al.
Publicado: (2011)

Pharmacological Management of Obesity in Patients with Polycystic Ovary Syndrome
por: Kourtidou, Christodoula, et al.
Publicado: (2023)

Obesity and Hyperandrogenemia in Polycystic Ovary Syndrome: Clinical Implications
por: López-Alarcón, Mardia, et al.
Publicado: (2023)

Serum Vitamin D Levels in Fertile and Infertile Women with Polycystic Ovary Syndrome
por: Kokanalı, Demet, et al.
Publicado: (2019)

Effects of Vitamin D on Fertility, Pregnancy and Polycystic Ovary Syndrome—A Review
por: Várbíró, Szabolcs, et al.
Publicado: (2022)

The Boosting Effects of Melatonin on the In Vitro Fertilization (IVF) of Women with Polycystic Ovary Syndrome
por: Pilehvari, Shamim, et al.
Publicado: (2023)

Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
por: Singh, Samradhi, et al.
Publicado: (2023)

Prevalence of macroprolactinaemia in regularly menstruating women with non-toxic goitre or autoimmune thyroid disease
por: Lewandowski, Krzysztof C, et al.
Publicado: (2012)

Cannabinoids: A New Group of Agonists of PPARs
por: Sun, Yan, et al.
Publicado: (2007)

Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility
por: Calcaterra, Valeria, et al.
Publicado: (2021)

Obesity and Outcome of Assisted Reproduction in Patients With Polycystic Ovary Syndrome
por: Tziomalos, Konstantinos, et al.
Publicado: (2018)

Prohibitin-induced obesity leads to anovulation and polycystic ovary in mice
por: Ande, Sudharsana Rao, et al.
Publicado: (2017)

Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Bioinformatics analysis of the molecular mechanism of obesity in polycystic ovary syndrome
por: Zhou, Jiaojiao, et al.
Publicado: (2021)

Delta neutrophil index in obese and non-obese polycystic ovary syndrome patients
por: Günday, Özlem Kayacık, et al.
Publicado: (2023)

Comparison of leptin concentrations between infertile women with polycystic ovary syndrome and fertile women
por: Dayer, Dian, et al.
Publicado: (2013)

Comparison of in vitro maturation and in vitro fertilization for polycystic ovary syndrome patients—reply letter
por: Xu, Yalan, et al.
Publicado: (2022)

The Effect of Sperm DNA Fragmentation on In Vitro Fertilization Outcomes for Women With Polycystic Ovary Syndrome
por: Wang, Huan, et al.
Publicado: (2022)

Unusual suspects: Glial cells in fertility regulation and their suspected role in polycystic ovary syndrome
por: Desroziers, Elodie
Publicado: (2022)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Cannabinoid Receptor 1 Gene Polymorphisms and Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome and in Healthy Controls
por: Kuliczkowska Plaksej, Justyna, et al.
Publicado: (2014)

Ibuprofen Reduces Testosterone Level in Women With Polycystic Ovary Syndrome
por: Banaszewska, Beata, et al.
Publicado: (2022)

Limitations of insulin resistance assessment in polycystic ovary syndrome
por: Lewandowski, Krzysztof C, et al.
Publicado: (2018)

Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
por: Gateva, Antoaneta, et al.
Publicado: (2012)

The correlation of aromatase activity and obesity in women with or without polycystic ovary syndrome
por: Chen, Jie, et al.
Publicado: (2015)

Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
por: Rojas, Joselyn, et al.
Publicado: (2014)

Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity
por: Couto Alves, A, et al.
Publicado: (2017)

Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome
por: Deng, Yuying, et al.
Publicado: (2017)

Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies
por: Barber, Thomas M, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tidt8dnt7k13i0gp81g5fok4uh